A look at Celldex Therapeutics Inc. — New Support Level

by DAN Celldex Therapeutics Inc. ($CLDX) averages are at $25.84 (21 day SMA), $25.22 (50 day SMA), $21.58 (200 day SMA). Over the past 52 weeks CLDX has traded from a low of $6.90 to a high of $38.84. CLDX was last at $26.99 on a volume of 650,620. Average daily volume has been at 2,219,283.

52 Week Range $6.90-$38.84 Market Cap 2,181,860,160 Average Volume 2,219,283 Dividend Yield 0.00% Institutional Ownership 86.50% Insider Ownership: 13.40% Percentage of Float Short 12.20% Beta 2.02

Celldex Therapeutics (CLDX) has been in consolidation for the last few months after reaching an extreme bullish move up to $40. The stock has been oscillating on either side of the 50-day moving average but appears to be finding support at that key indicator. The current reading is $25. Technical traders should be keeping an eye on this important level. New long positions could be protected by placing a stop just below support.

Celldex Therapeutics, Inc., is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.

Articles